Daiwa Securities raised the price target for the Johnson & Johnson (NYSE:JNJ) stock to ‘an Outperform’. The rating was released on June 22, 2023, according to finviz. The research report from Morgan Stanley has resumed the stock to Equal-Weight, with a price target set at $173. The stock was downgraded by Bernstein, who disclosed in a research note on March 16, 2023, from Outperform to Mkt Perform and set the price objective to $183. In their research brief published March 02, 2023, BofA Securities analysts resumed the Johnson & Johnson stock to Neutral with a price target of $185.